Decreased Hsp90 activity protects against TDP-43 neurotoxicity in a C. elegans model of amyotrophic lateral sclerosis
Open Access
- 26 December 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 20 (12) , e1011518
Abstract
Neuronal inclusions of hyperphosphorylated TDP-43 are hallmarks of disease for most patients with amyotrophic lateral sclerosis (ALS). Mutations in TARDBP, the gene coding for TDP-43, can cause some cases of familial inherited ALS (fALS), indicating dysfunction of TDP-43 drives disease. Aggregated, phosphorylated TDP-43 may contribute to disease phenotypes; alternatively, TDP-43 aggregation may be a protective cellular response sequestering toxic protein away from the rest of the cell. The heat shock responsive chaperone Hsp90 has been shown to interact with TDP-43 and stabilize its normal conformation; however, it is not known whether this interaction contributes to neurotoxicity in vivo. Using a C. elegans model of fALS mutant TDP-43 proteinopathy, we find that loss of function of HSP-90 protects against TDP-43 neurotoxicity and subsequent neurodegeneration in adult animals. This protection is accompanied by a decrease in both total and phosphorylated TDP-43 protein. We also find that hsp-90 mutation or inhibition upregulates key stress responsive heat shock pathway gene expression, including hsp-70 and hsp-16.1, and we demonstrate that normal levels of hsp-16.1 are required for hsp-90 mutation effects on TDP-43. We also observe that the neuroprotective effect due to HSP-90 dysfunction does not involve direct regulation of proteasome activity in C. elegans. Our data demonstrate for the first time that Hsp90 chaperone activity contributes to adverse outcomes in TDP-43 proteinopathies in vivo using a whole animal model of ALS.Keywords
Funding Information
- U.S. Department of Veterans Affairs (I01BX004044)
- National Institute on Aging (R01AG066729)
- National Institute of Health (R35GM142728)
This publication has 112 references indexed in Scilit:
- The Hsp70–Hsp90 go-between Hop/Stip1/Sti1 is a proteostatic switch and may be a drug target in cancer and neurodegenerationCellular and Molecular Life Sciences, 2021
- Hsp70 – a master regulator in protein degradationFEBS Letters, 2017
- Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasisCell Stress and Chaperones, 2013
- The small heat shock proteins αB-crystallin and Hsp27 suppress SOD1 aggregation in vitroCell Stress and Chaperones, 2013
- CDC7 inhibition blocks pathological TDP‐43 phosphorylation and neurodegenerationAnnals of Neurology, 2013
- Evolution and function of diverse Hsp90 homologs and cochaperone proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseasesDevelopmental Dynamics, 2010
- Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP‐43Journal of Neuroscience Research, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Nuclear localization of two steroid receptor-associated proteins, hsp90 and p59Experimental Cell Research, 1990